Day: February 3, 2016
Indian Patent Office rejects compulsory license application for AstraZeneca’s Saxagliptin
Patents are generally granted to encourage inventions and to protect the rights of the inventor. However, the Indian Patent Act serves to strike a balance between protecting the rights of the inventor and making such patented products available to people at large for the betterment of the society,…
